Sign In
Buy CLPBF
$57.28
-2.41 (-4.03%)
At Close: Jun 02, 2026
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
11:52am, Thursday, 09'th Oct 2025
Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has tod
Coloplast A/S - Financial Calendar 2025-26
08:39am, Tuesday, 30'th Sep 2025
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://www.coloplast.com/investor-relations/events-calendar/ Kind regards,Investor Relations
Coloplast A/S (CLPBY) Capital Markets Day 2025 Transcript
03:30pm, Tuesday, 02'nd Sep 2025
Coloplast A/S (OTCPK:CLPBY) Capital Markets Day 2025 September 2, 2025 4:30 AM EDT Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Caroline Rosenstand - Executive Vic
Coloplast A/S (CLPBF) Q3 2025 Earnings Call Transcript
12:33pm, Tuesday, 19'th Aug 2025
Coloplast A/S (OTCPK:CLPBF) Q3 2025 Earnings Conference Call August 19, 2025 5:00 AM ET Company Participants Anders Lonning-Skovgaard - Executive VP & CFO Lars Soren Rasmussen - Interim CEO & Director
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
09:44am, Tuesday, 19'th Aug 2025
Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For thos
Coloplast: Finally Getting Buyable
11:00am, Saturday, 14'th Jun 2025
Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core segments. Despite a 20% share price drop, I see upside potential, b
Coloplast A/S (CLPBF) Q2 2025 Earnings Call Transcript
04:36am, Saturday, 10'th May 2025
Coloplast A/S (OTCPK:CLPBF) Q2 2025 Earnings Conference Call May 6, 2025 5:00 AM ET Company Participants Lars Søren Rasmussen - Interim CEO Anders Lonning-Skovgaard - Chief Financial Officer Conferen
Coloplast A/S CEO Kristian Villumsen steps down as of today
11:11am, Monday, 05'th May 2025
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO.
Coloplast A/S (CLPBF) Q1 2025 Earnings Call Transcript
02:23pm, Tuesday, 04'th Feb 2025
Coloplast A/S (OTCPK:CLPBF) Q1 2025 Results Conference Call February 4, 2025 5:00 AM ET Company Participants Kristian Villumsen - Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Off
Coloplast Finance B.V. - Interim Financial Report, Q1 2024/25
08:27am, Tuesday, 04'th Feb 2025
2024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue in
Coloplast A/S - Allocation of Share Options
07:12am, Tuesday, 04'th Feb 2025
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactio
Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET
09:08am, Tuesday, 21'st Jan 2025
Tuesday, 4 February 2025 at 10.00 - 11.00am CET In connection with the publication of Coloplast's interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will h
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
09:54am, Wednesday, 11'th Dec 2024
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
Coloplast A/S - Decisions at the Annual General Meeting 2024
11:11am, Thursday, 05'th Dec 2024
Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved. Distribution of y
Coloplast A/S (CLPBF) Q4 2024 Earnings Call Transcript
08:26am, Saturday, 09'th Nov 2024
Coloplast A/S (OTCPK:CLPBF) Q4 2024 Earnings Conference Call November 5, 2024 5:00 AM ET Company Participants Nicholas Seibert - Vice President of Corporate Development & Investor Relations Kristian V
